The long road to elimination: malaria mortality in a South African population cohort over 21 years

por Byass, P., Collinson, M. A., Kabudula, C., Gómez-Olivé, F. X., Wagner, R. G., Ngobeni, S., Silaule, B., Mee, P., Coetzee, M., Twine, W., Tollman, S. M., Kahn, K.
Publicado 2017

A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)

por Hall, P S, Lord, S R, Collinson, M, Marshall, H, Jones, M, Lowe, C, Howard, H, Swinson, D, Velikova, G, Anthoney, A, Roy, R, Dent, J, Cheeseman, S, Last, K, Seymour, M T
Publicado 2017

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

por Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.
Publicado 2018